
1. J Cyst Fibros. 2020 Sep 16. pii: S1569-1993(20)30866-3. doi:
10.1016/j.jcf.2020.09.004. [Epub ahead of print]

Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis
despite chronic azithromycin therapy.

Richter WJ(1), Nguyen JA(1), Wu AE(1), Jennings MT(1), Lechtzin N(1), Parrish
NM(2), Psoter KJ(3), Cohen KA(4).

Author information: 
(1)Division of Pulmonary and Critical Care Medicine, Johns Hopkins University
School of Medicine, 1830 E. Monument St., 5th Floor, Baltimore, MD, 21287, USA.
(2)Department of Pathology, Johns Hopkins University School of Medicine,
Baltimore, MD, USA.
(3)Department of Pediatrics, Johns Hopkins University School of Medicine,
Baltimore, MD, USA.
(4)Division of Pulmonary and Critical Care Medicine, Johns Hopkins University
School of Medicine, 1830 E. Monument St., 5th Floor, Baltimore, MD, 21287, USA.
Electronic address: kcohen8@jhmi.edu.

DOI: 10.1016/j.jcf.2020.09.004 
PMID: 32950412 

Conflict of interest statement: Declaration of Competing Interest Keira Cohen
reports personal fees from Insmed, Hillrom and Merck, outside the submitted work.
Jan Nguyen reports fees from AstraZeneca, outside the submitted work. Mark
Jennings reports fees from Hillrom, Merck, and Savara outside the submitted work.
William Richter, Andrew Wu, Noah Lechtzin, Kevin Psoter, and Nicole Parrish
declare there are no conflicts of interest related to this work.

